Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Mildronate-Derived Lipidoids Minimize Inflammation in mRNA D
2026-07-08
The referenced ACS Nano study introduces mildronate-derived cationic lipidoids (mLPs) as low-dose components for lipid nanoparticles, enabling efficient mRNA vaccine delivery with significantly reduced inflammatory side effects. These findings offer a promising route to safer mRNA-based immunotherapies and inform best practices for immunogen delivery in preclinical research.
5-Azacytidine Induces ATR-Mediated DNA Damage in Myeloma Cel
2026-07-07
This study demonstrates that 5-Azacytidine, a DNA methyltransferase inhibitor, triggers ATR-mediated DNA double-strand break responses and apoptosis in both therapy-sensitive and resistant multiple myeloma cells. The findings reveal synergistic cytotoxicity when combined with doxorubicin or bortezomib, highlighting its promise for overcoming drug resistance in myeloma research.
Temozolomide: Strategic DNA Damage Catalyst for Translationa
2026-07-07
This thought-leadership article explores the mechanistic and translational value of Temozolomide as a small-molecule alkylating agent in glioma research. It integrates recent findings on ATRX-deficient high-grade gliomas, highlights evidence-backed experimental and clinical strategies, and frames the competitive landscape, while offering actionable protocol guidance for translational researchers. The article situates APExBIO’s Temozolomide as a benchmark tool and advances the conversation beyond conventional product overviews, linking to foundational and advanced resources.
Pemetrexed in Chemotherapy: Mechanistic Insights for Precisi
2026-07-06
Explore how pemetrexed, a multi-targeted antifolate, advances cancer chemotherapy research through mechanism-driven assays and synergy with DNA repair defects. This article offers a distinct, in-depth perspective on pemetrexed disodium's applications and protocol optimization.
Vidarabine Monohydrate: Optimizing Antiviral DNA Interferenc
2026-07-06
Vidarabine monohydrate (Spongoadenosine monohydrate) enables precise, reproducible inhibition of viral DNA synthesis in advanced virology research. Explore stepwise workflows, troubleshooting guidance, and actionable strategies to maximize assay sensitivity and reliability—backed by unique insights from recent cross-domain innovations.
Biotin-HPDP: Precision Thiol Labeling for Protein Analysis
2026-07-05
Biotin-HPDP empowers researchers with reversible, thiol-specific protein biotinylation, crucial for dissecting redox-sensitive modifications and affinity purification workflows. Its unique chemistry ensures selectivity and controlled release, enabling advanced applications in immunology and cell death research.
ONX-0914 (PR-957): Advancing Immunoproteasome Inhibition Wor
2026-07-04
ONX-0914 (PR-957) empowers researchers to dissect immunoproteasome function with unmatched selectivity, enabling reliable cytokine blockade and disease modeling in autoimmune and inflammatory research. Discover protocol enhancements, troubleshooting tips, and translational insights inspired by cutting-edge mechanistic studies.
GSK J4 HCl: Precision JMJD3 Inhibitor for Epigenetic Researc
2026-07-03
GSK J4 HCl stands out as a potent, cell-permeable JMJD3 inhibitor optimized for dissecting histone methylation dynamics in inflammation and disease. This article delivers practical workflows, troubleshooting strategies, and fresh insights for leveraging GSK J4 HCl—bridging bench research with translational applications in immune regulation.
2X Taq PCR Master Mix: Advanced PCR Workflows & Troubleshoot
2026-07-03
The 2X Taq PCR Master Mix (with dye) streamlines DNA amplification with direct gel loading, making it ideal for genotyping, TA cloning, and translational research. Discover enhanced experimental workflows, practical troubleshooting, and new insights from recent glycosylation studies using this robust molecular biology PCR reagent.
Cefotaxime Applications in Antimicrobial Resistance Models
2026-07-02
Cefotaxime, a third-generation cephalosporin antibiotic, empowers researchers to dissect antimicrobial resistance dynamics and optimize bacterial infection models. This article delivers practical workflows, troubleshooting strategies, and evidence-driven insights that help laboratories leverage Cefotaxime for advanced AMR studies.
Virus Flexibility Enables Selective Capture of Rare Target C
2026-07-02
The referenced study introduces a flexible phage nanofiber platform to selectively isolate rare circulating tumor cells (CTCs) from blood, dramatically improving binding affinity and anti-fouling compared to traditional rigid capture surfaces. This innovation advances cancer subtyping precision and highlights the significance of viral mechanical properties in bioassay design.
Calpain Inhibitor I, ALLN: Technical Use in Apoptosis and In
2026-07-01
Calpain Inhibitor I, ALLN is a potent, selective inhibitor for calpain and cathepsin proteases, enabling precise blockade in apoptosis assays, ischemia-reperfusion injury models, and inflammation research. It is not intended for diagnostic or clinical use, and requires careful attention to solubility and storage conditions for reproducible results.
Valemetostat (DS-3201) for EZH2 Mutant Lymphoma Research
2026-07-01
Valemetostat (DS-3201) empowers translational epigenetic cancer workflows with unmatched selectivity for EZH2 wild-type and mutant forms. This article details practical protocols, advanced troubleshooting, and data-driven strategies for maximizing research outcomes using APExBIO’s validated reagent.
EZ Cap™ Cas9 mRNA (m1Ψ): Enhanced Precision in Genome Editin
2026-06-30
EZ Cap™ Cas9 mRNA (m1Ψ) delivers advanced genome editing with improved translation efficiency and minimized immune response, thanks to its Cap1 structure and m1Ψ modification. This reagent from APExBIO empowers researchers to achieve high-specificity CRISPR-Cas9 editing in mammalian cells, with streamlined workflows and robust reproducibility.
Mutant-Specific Reactivation of p53Y220C via Chemically Indu
2026-06-30
This study introduces TRAP-1, a small molecule that selectively reactivates the p53Y220C mutant by inducing a ternary complex with BRD4, restoring transcriptional activity and inhibiting cancer cell growth. The findings highlight a new paradigm in targeting tumor suppressor mutations using chemically induced proximity.
8150 records 16/544 page Previous Next First page 上5页 1617181920 下5页 Last page